Adverse cutaneous drug reaction

Area of Science:

• Dermatology
• Clinical Pharmacology
• Internal Medicine

Background:

• Adverse cutaneous drug reactions (ACDR) are frequently encountered by physicians in daily practice.
• Many ACDR cases are underreported, leading to a lack of comprehensive data on incidence, severity, and health outcomes.
• The continuous introduction of new drugs increases the potential for novel or undocumented drug reactions.

Purpose of the Study:

• To emphasize the importance of early identification and management of ACDR.
• To highlight the challenges in diagnosing ACDR, especially in patients with multiple medications.
• To focus on the pathomechanism and diagnostic approach for ACDR.

Main Methods:

• Clinical observation and judgment are the primary methods for diagnosing ACDR.
• Understanding the pathomechanism of drug-host interactions is key.
• The discussion centers on diagnostic strategies rather than specific treatments.

Main Results:

• Diagnosis of ACDR is primarily based on clinical judgment due to complex presentations and limited confirmatory testing.
• Early identification and withdrawal of the offending drug are critical for preventing severe reactions.
• Familiarity with ACDR presentation and diagnostic approaches is essential for all physicians.

Conclusions:

• Physicians must be equipped to diagnose and manage ACDR effectively.
• A thorough understanding of ACDR pathomechanisms aids in diagnosis.
• Clinical judgment remains the cornerstone for diagnosing ACDR in complex cases.